NICOLE LIBERT: Open Payments
NPI 1578285557 · COLUMBIA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 39 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $383 · 2025 $1,258
Food & beverage: $1,258
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $349 |
| Vanda Pharmaceuticals Inc. | 6 | $249 |
| E.R. Squibb & Sons, L.L.C. | 6 | $230 |
| Alkermes, Inc. | 4 | $120 |
| Neurocrine BioSciences, Inc. | 3 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: CAPLYTA, COBENFY, FANAPT, ARISTADA, INGREZZA, HETLIOZ, REXULTI, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
